BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
IGF1
,
T cell differentiation
,
Inflammatory disorder
,
Kidney
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclopentane
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Acute erythroleukemia HEL cells treated with ruxolitinib, pevonedistat, or both
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Colorectal cancer HCT 116 cells with CTNNB1 knockdown or Wnt signaling pathway inhibition
Explore Curated Studies Results
Literature
Most Relevant Literature
Enantioselective Construction of Spirooxindole-Fused Cyclopentanes.
Regiodivergent Palladium-Catalyzed Alkene Difunctionalization Reactions for the Construction of Meth…
Multicomponent Domino Reaction in the Asymmetric Synthesis of Cyclopentan[c]pyran Core of Iridoid Na…
Diastereomerically pure rarely functionalized alkenoyl dihydropyrans, 1,6-diketones, and cyclopentan…
Catalytic asymmetric desymmetrization approaches to enantioenriched cyclopentanes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ticagrelor and Peripheral Arterial Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ